Association of immune checkpoint inhibitor-induced bullous pemphigoid with underlying cancer type: A lack of association with cancer tissue COL17A1 mutations and dysregulation | Synapse
January 13, 2026Open Access
Association of immune checkpoint inhibitor-induced bullous pemphigoid with underlying cancer type: A lack of association with cancer tissue COL17A1 mutations and dysregulation
Key Points
Key points are not available for this paper at this time.
Abstract
mutations or dysregulation do not appear to drive this phenomenon, suggesting alternative immune mechanisms.